Results

Total Results: 2,078 records

Showing results for "drugs".

81. Evidence Summary for CER 239: Acute Treatments for Episodic Migraine (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
    December 01, 2020 - Points • Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti- inflammatory drugs … Some opioids may be less effective than other drugs. … Results Evidence on triptans and nonsteroidal anti-inflammatory drugs (NSAIDs) was summarized from … In terms of applicability, several of the established drugs, such as the ergot alkaloids, may not be … In general, adverse events of these drugs are mild and transient.

82. Health Literacy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/health-literacy
    September 30, 2009 - Protocol Archived December 6, 2011 Communicating Harms and Benefits of Prescription Drugs

83. Topic Coming Back CER 28 DMARDs in Children with JIA NSD _SJ Clean (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
    March 27, 2014 - Disease-Modifying Antirheumatic Drugs … Document Results of Topic Selection Process & Next Steps § The topic, Disease-Modifying Antirheumatic Drugs … Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA). … update surveillance of Comparative Effectiveness Review (CER) #28: Disease-Modifying Antirheumatic Drugs

84. Kravitz_ECCS2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
    January 01, 2012 - Slide 6: Direct-­‐to-­‐Consumer Advertising  of Prescription Drugs … Products Patients Remembered Seeing Advertised Percentage of Patients Who Requested Advertised Drugs … condemnation cycle Slide 11: Evaluating  the Accuracy and Balance of Media Reports  on Prescription Drugs … Journalists  are  now in a difficult position with  regard  to  reporting on prescription  drugs … • HealthNewsReview.org gives expert, independent review of media reports on prescription drugs and

85. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - Boston (MA): Vertex Pharmaceuticals, Inc.; 2014 Nov 05 [accessed 2014 Dec 11]. [3 p]. … Boston (MA): Vertex Pharmaceuticals Incorporated [accessed 2015 Dec 10]. [2 p]. … MannKind Corporation, Takeda Pharmaceuticals America, Inc, Genentech USA, Inc. … Boehringer Ingelheim Pharmaceuticals, Inc. … Ridgefield (CT): Boehringer Ingelheim Pharmaceuticals, Inc.; 2014 Oct. 18 p.

86. Medicare-Medication-Use Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
    April 01, 2014 - Care for chronic physical and psychiatric conditions often includes the use of multiple prescription drugs … Medicare Part D program between 2005 and 2006, Medicare expenditures for outpatient prescription drugs … Drugs are consolidated into 95 drug groups, and drug groups are consolidated into 18 drug categories … Antipsychotic use: We considered beneficiaries to be using antipsychotic or antimanic drugs if they … Neuromuscular drugs Anticonvulsants Cardiovascular agents Diuretics Neuromuscular drugs Antimyasthenic

87. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - Given the limited pharmacologic treatment options for obesity, additional pharmaceuticals intended … San Diego (CA): Arena Pharmaceuticals, Inc; 2010 Nov 09 [accessed 2011 Dec 16]. [3 p]. … Washington (DC): Arena Pharmaceuticals, Inc.; 2009 Oct 27 [accessed 2011 Apr 21]. [4 p]. … San Diego (CA): Arena Pharmaceuticals, Inc.; 2010 Jul 01 [accessed 2014 Apr 29]. [3 p]. … San Diego (CA): Arena Pharmaceuticals; 2012 Jun 27 [accessed 2012 Jul 05]. [4 p].

88. Dietary Supplements in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/dietary-supplements/

89. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - San Diego (CA): Arena Pharmaceuticals, Inc; 2010 Nov 9 [accessed 2011 Dec 16]. [3 p]. … Washington (DC): Arena Pharmaceuticals, Inc.; 2009 Oct 27 [accessed 2011 Apr 21]. [4 p]. … San Diego (CA): Arena Pharmaceuticals, Inc.; 2009 Dec 22 [accessed 2012 Mar 26]. [2 p]. … San Diego (CA): Arena Pharmaceuticals; 2012 Jun 27 [accessed 2012 Jul 5]. [4 p]. … Arena Pharmaceuticals. Lorcaserin hydrochloride. Drugs Future. 2007;32(9):766-70. 77.

90. Ventricular Arrhythmias and Cerebrovascular Events in the Elderly Using Conventional and Atypical Antipsychotic Medications | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/antipsychotic-medicine-cardiovascular-elderly/research
    March 18, 2009 - 10 Another observational study found higher mortality in those given haloperidol vs. two atypical drugs … FDA warns antipsychotic drugs may be risky for elderly. JAMA 2005;293:2462. 3. Strong C. … Using antipsychotic agents in older patients: expert consensus panel for using antipsychotic drugs in … Antipsychotic drugs: prolonged QTc Interval, Torsade de Pointes, and sudden death. … Antipsychotic drugs in dementia: what should be made of the risks? JAMA 2005;294:1963-1965.

91. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
    May 19, 2010 - These drugs have been studied for off-label use in several conditions. … published studies on atypical antipsychotics and found that the most common off-label uses of the drugs … treatment for agitation in dementia, association between the increased risk of death and antipsychotics drugs … Sub-Question 2: How do atypical antipsychotic medications compare with other drugs, including first … How do they compare within the class and with other drugs used for the conditions?

92. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
    October 01, 2015 - Cambridge (MA): Vertex Pharmaceuticals, Inc.; 2011 Nov 03 [accessed 2014 Apr 10]. [4 p]. … Cambridge (MA): Vertex Pharmaceuticals, Inc.; 2010 Nov 08 [accessed 2011 Jan 04]. [1 p]. … Boston (MA): Vertex Pharmaceuticals, Inc.; 2014 Nov 05 [accessed 2014 Dec 11]. [3 p]. … Boehringer Ingelheim Pharmaceuticals, Inc. … Ridgefield (CT): Boehringer Ingelheim Pharmaceuticals, Inc.; 2014 Oct. 18 p.

93. #06 Developmental Delays ADHD, and Autism (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
    January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … These drugs will likely face intense scrutiny, considering the challenges of accurately diagnosing

94. Comparative Effectiveness of Oral Hypoglycemics for Reducing Diabetic Nephropathy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/diabetes-oral-medicines-nephropathy/research
    January 01, 2005 - Comparative effectiveness research using electronic health records: impacts of oral antidiabetic drugs

95. Methods-Guidance-Reporting-Bias Methods (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
    November 01, 2013 - Regulatory Documents Reviews of Drugs Compared With Devices Drugs and devices are both regulated by … • Reviewers should search Drugs@FDA for information on drugs; if a search is not conducted reviewers … However, the Web site typically does not have documents related to older drugs and very new drugs. … International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals … For drugs: generic name, or temporary identifier for drugs that do not yet have a generic name; for

96. Data Points #19: Medication Use in Medicare | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/medicare-medication-use/research
    April 23, 2014 - Care for chronic physical and psychiatric conditions often includes the use of multiple prescription drugs … Multiple medications and use of psychotropic drugs increases the possibility of adverse drug events. … the Medicare Part D program between 2005 and 2006, Medicare expenditures for outpatient prescription drugs

97. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - San Diego (CA): Arena Pharmaceuticals, Inc; 2010 Nov 9 [accessed 2011 Dec 16]. [3 p]. … New data from Arena Pharmaceuticals' pivotal BLOSSOM trial of lorcaserin demonstrate improvements … Washington (DC): Arena Pharmaceuticals, Inc.; 2009 Oct 27 [accessed 2011 Apr 21]. [4 p]. … San Diego (CA): Arena Pharmaceuticals; 2012 Jun 27 [accessed 2012 Jul 5]. [4 p]. … Arena Pharmaceuticals. Lorcaserin hydrochloride. Drugs Future. 2007;32(9):766-70. 78.

98. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
    January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative or … Peripheral and Central Nervous System Drugs Advisory Committee.

99. Comparative Effectiveness and Safety: Emerging Methods - Part I | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/safety-emerging-methods/executive
    September 25, 2007 - Assessment of Adherence to and Persistence on Disease-Modifying Antirheumatic Drugs (DMARDs) in Patients … Assessment of Adherence to and Persistence on Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Patients … Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic … Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic

100. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
     April 01, 2020 - Finally, although only a few prescription drugs are approved by the U.S. … – There was minimal evidence addressing whether efficacy of prescription drugs for CATD treatment … (n=454), and five that compared prescription drugs with supplements (n=258). … Two trials compared different prescription drugs (n=414). … Evidence on the efficacy and harms of CATD drugs had several limitations.